Torkhovskaia TI - Search Results

1

[Bioavailability of oral drug formulations and methods for its improvement].

Ipatova OM, Torkhovskaia TI, Medvedeva NV, Prozorovskiĭ VN, Ivanova ND, Shironin AV, Baranova VS, Archakov AI. Ipatova OM, et al. Among authors: torkhovskaia ti. Biomed Khim. 2010 Jan-Feb;56(1):101-19. doi: 10.18097/pbmc20105601101. Biomed Khim. 2010. PMID: 21328915 Review. Russian.

2

[The increase of bioavailability and anti-inflammatory effect of indomethacin loaded into phospholipid nanoparticles].

Shironin AV, Ipatova OM, Medvedeva NV, Prozorovskiĭ VN, Tikhonova EG, Zakharova TS, Sanzhakov MA, Torkhovskaia TI. Shironin AV, et al. Among authors: torkhovskaia ti. Biomed Khim. 2011 Nov-Dec;57(6):671-6. Biomed Khim. 2011. PMID: 22359924 Russian.

3

[Membrane proteins and phospholipids as effectors of reverse cholesterol transport].

Torkhovskaia TI, Ipatova OM, Medvedeva NV, Zakharova TS, Khalilov EM. Torkhovskaia TI, et al. Biomed Khim. 2006 Mar-Apr;52(2):113-23. Biomed Khim. 2006. PMID: 16805382 Review. Russian.

4

[Antirheumatoid activity of methotrexate in phospholipid nanoparticles (Phosphogliv)].

Zykova MG, Prozorovskiĭ VN, Ipatova OM, Torkhovskaia TI, Glazatov VV. Zykova MG, et al. Among authors: torkhovskaia ti. Biomed Khim. 2007 Jul-Aug;53(4):435-41. Biomed Khim. 2007. PMID: 18035724 Russian.

5

[Comatose states: etiopathogenesis, experimental studies, treatment of hepatic coma].

Strekalova OS, Uchaĭkin VF, Ipatova OM, Torkhovskaia TI, Medvedeva NV, Storozhakov GI, Archakov AI. Strekalova OS, et al. Among authors: torkhovskaia ti. Biomed Khim. 2009 Jul-Aug;55(4):380-96. Biomed Khim. 2009. PMID: 20000119 Review. Russian.

6

[Plasma lipoproteins as drug carriers. Effect of phospholipid formulations].

Torkhovskaia TI, Ipatova OM, Medvedeva NV, Ivanov VS, Ivanova LI. Torkhovskaia TI, et al. Vestn Ross Akad Med Nauk. 2010;(5):42-50. Vestn Ross Akad Med Nauk. 2010. PMID: 20608046 Review. Russian.

7

[Changes of doxorubicin distribution in blood and plasma after its inclusion into nanophospholipd formulation].

Zyova MA, Ipatova OM, Prozorovskiĭ VN, Medvedeva NV, Voskresenskaia AA, Zakharova TS, Torkhovskaia TI. Zyova MA, et al. Among authors: torkhovskaia ti. Biomed Khim. 2011 Mar-Apr;57(2):174-9. doi: 10.18097/pbmc20115702174. Biomed Khim. 2011. PMID: 21870602 Russian.

8

[Interaction of rifampicin embedded in phospholipid nanoparticles with blood plasma lipoproteins].

Sanzhakov MA, Ipatova OM, Prozorovskiĭ VN, Medvedeva NV, Torkhovskaia TI. Sanzhakov MA, et al. Among authors: torkhovskaia ti. Biomed Khim. 2014 May-Jun;60(3):348-53. doi: 10.18097/pbmc20146003348. Biomed Khim. 2014. PMID: 25019397 Russian.

9

[Hemorheological and clinical efficiency of a new phospholipid hepatoprotective drug Phosphogliv in patients with psoriatic arthritis].

Ipatova OM, Nasonov EL, Korotaeva TV, Firsov NN, Ivkina OA, Torkhovskaia TI, Archakov AI. Ipatova OM, et al. Among authors: torkhovskaia ti. Biomed Khim. 2003 Sep-Oct;49(5):484-90. Biomed Khim. 2003. PMID: 16119102 Clinical Trial. Russian.

10

[Possibilities for use of phospholipid nanosystem with glycyrrhizic acid ("phosphogliv") for optimization of drugs: doxorubicin and budesonide as examples].

Ipatova OM, Zykova MG, Prozorovskiĭ VN, Torkhovskaia TI, Zakharova TS. Ipatova OM, et al. Among authors: torkhovskaia ti. Biomed Khim. 2009 Mar-Apr;55(2):185-94. Biomed Khim. 2009. PMID: 19507342 Russian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters